Using a conditional allele of MITF activity, it has been shown that low levels of MITF activity cooperates with BRAF and/or p53 mutations to promote melanoma, whereas turning off MITF completely leads to melanoma regression (Lister et al., 2014; Travnickova et al., 2019). This evidence concerns the gene TP53 and melanoma.